CEO Emma Walmsley takes GlaxoSmithKline on a quest for identity
ANDY BUCHANAN/GETTY IMAGES
Walmsley took over GSK looking like the opposite of a pharma insider. Appearances may have been deceiving — because she’s betting on drugs.
Suscribirse a:
Enviar comentarios (Atom)
.png)
No hay comentarios:
Publicar un comentario